UNIVERSAL BIOSENSORS INC. - Announcements

8.33%

2.6¢

Market Cap $7.749M

Technology Scientific & Technical Instruments

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing... Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, women’s health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

UBI	Appendix 4E and Annual Report on Form 10-K FY2021	PRICE SENSITIVE	24/02/22	3.73MB	Share
UBI	December 2021 Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	28/01/22	364.92KB	Share
UBI	UBI launch Sentia Malic Acid Test globally	PRICE SENSITIVE	18/01/22	170.24KB	Share
UBI	UBI signs deal to commercialise SARS-CoV-2 N-Protein Test	PRICE SENSITIVE	24/12/21	425.13KB	Share
UBI	UBI signs Master Collaboration Agreement with Mayo Clinic	PRICE SENSITIVE	11/11/21	146.13KB	Share
UBI	Investor Presentation	PRICE SENSITIVE	11/11/21	449.93KB	Share
UBI	UBI signs Master Collaboration Agreement with Mayo Clinic	PRICE SENSITIVE	11/11/21	145.44KB	Share
UBI	Q3 2021 Results and Market Update	PRICE SENSITIVE	29/10/21	2.52MB	Share
UBI	UBI launches Regulatory Clinical Trial for Xprecia Prime	PRICE SENSITIVE	27/10/21	178.45KB	Share
UBI	UBI signs USA distribution deal and Sentia sales hit $1M	PRICE SENSITIVE	25/10/21	167.03KB	Share
UBI	September 2021 Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	22/10/21	295.43KB	Share
UBI	UBI receives $2.8M under the R&D Tax Incentive Rebate	PRICE SENSITIVE	11/10/21	167.15KB	Share
UBI	UBI signs major French distribution deal for Sentia	PRICE SENSITIVE	04/10/21	168.82KB	Share
UBI	UBI extends clinical development trials for Tn Antigen	PRICE SENSITIVE	20/09/21	150.85KB	Share
UBI	Peter Mac - Tn Antigen cancer biosensor trial	PRICE SENSITIVE	14/09/21	166.51KB	Share
UBI	Market Update	PRICE SENSITIVE	09/09/21	340.66KB	Share
UBI	Appendix 4D and Half Year Results - 30 June 2021	PRICE SENSITIVE	06/08/21	616.43KB	Share
UBI	June 2021 Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	30/07/21	370.87KB	Share
UBI	CEO's AGM Address to Shareholders	PRICE SENSITIVE	30/06/21	550.72KB	Share
UBI	Sentia Sales Update	PRICE SENSITIVE	07/06/21	174.74KB	Share
UBI	Q1 2021 Results	PRICE SENSITIVE	30/04/21	355.73KB	Share
UBI	UBI signs New Zealand distribution deal for Sentia	PRICE SENSITIVE	29/04/21	193.32KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/21	330.53KB	Share
UBI	UBI signs South Africa distribution deal for Sentia	PRICE SENSITIVE	26/04/21	192.08KB	Share
UBI	UBI signs USA distribution deal for Sentia	PRICE SENSITIVE	15/04/21	169.04KB	Share
UBI	UBI signs Chilean distribution deal for Sentia	PRICE SENSITIVE	14/04/21	166.42KB	Share
UBI	UBI signs exclusive deal with Deakin and Swinburne	PRICE SENSITIVE	13/04/21	141.41KB	Share
UBI	UBI signs global supply agreement for new technology	PRICE SENSITIVE	09/04/21	417.95KB	Share
UBI	UBI signs exclusive agreement for cancer biosensor	PRICE SENSITIVE	09/04/21	708KB	Share
UBI	Trading Halt	PRICE SENSITIVE	07/04/21	252.64KB	Share
UBI	Pause in Trading	PRICE SENSITIVE	07/04/21	116.09KB	Share
UBI	UBI signs Canadian distribution deal	PRICE SENSITIVE	01/04/21	167.55KB	Share
UBI	Appendix 4E and Annual Report on Form 10-K FY2020	PRICE SENSITIVE	24/02/21	702.62KB	Share
UBI	The Future of UBI	PRICE SENSITIVE	09/02/21	712.43KB	Share
UBI	31 December 2020 Quarterly Activity & Cashflow Report	PRICE SENSITIVE	29/01/21	321.42KB	Share
UBI	UBI signs USA distribution deal	PRICE SENSITIVE	27/01/21	176.55KB	Share
UBI	UBI's Canadian subsidiary signs deal with Bayer AG	PRICE SENSITIVE	30/12/20	171.89KB	Share
UBI	UBI Signs Global Deal with LifeScan	PRICE SENSITIVE	22/12/20	173.46KB	Share
UBI	Australian Distributor Agreement for Sentia	PRICE SENSITIVE	07/12/20	176.61KB	Share
UBI	Comparison Validation Study Result for Sentia	PRICE SENSITIVE	24/11/20	206.68KB	Share
UBI	UBI receives $2.8 million as R&D Tax Incentive	PRICE SENSITIVE	04/11/20	174KB	Share
UBI	Q3 2020 Results	PRICE SENSITIVE	29/10/20	579.24KB	Share
UBI	30 September 2020 Quarterly Activity Report	PRICE SENSITIVE	19/10/20	376.47KB	Share
UBI	Update - Coagulation Business Update	PRICE SENSITIVE	08/10/20	215.85KB	Share
UBI	Coagulation Business Update	PRICE SENSITIVE	06/10/20	215.65KB	Share
UBI	Appendix 4D and Half Year Results - 30 June 2020	PRICE SENSITIVE	24/07/20	696.91KB	Share
UBI	CEO's AGM Address to Shareholders	PRICE SENSITIVE	24/07/20	1.92MB	Share
UBI	30 June 2020 Quarterly Activity Report	PRICE SENSITIVE	17/07/20	280.85KB	Share
UBI	Form 603 - JM Financial Group Limited	PRICE SENSITIVE	10/07/20	259.12KB	Share
UBI	Q1 2020 Results	PRICE SENSITIVE	24/04/20	319.88KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	20/04/20	250.12KB	Share
UBI	Appointment of CEO	PRICE SENSITIVE	06/03/20	162.91KB	Share
UBI	FY2019 Results Presentation	PRICE SENSITIVE	26/02/20	6.48MB	Share
UBI	Appendix 4E and Annual Report on Form 10-K FY2019	PRICE SENSITIVE	26/02/20	662.47KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	24/01/20	265.78KB	Share
UBI	Q3 2019 Results	PRICE SENSITIVE	04/11/19	340.6KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/19	264.27KB	Share
UBI	UBI & Siemens Execute Definitive Agreements	PRICE SENSITIVE	23/09/19	59.05KB	Share
UBI	Siemens Negotiations, Business Update and On-Market Buy-Back	PRICE SENSITIVE	09/09/19	278.5KB	Share
UBI	Term Sheet Extension	PRICE SENSITIVE	22/08/19	61.46KB	Share
UBI	Appendix 4D and Half Year Results - 30 June 2019	PRICE SENSITIVE	25/07/19	597.69KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	16/07/19	393.59KB	Share
UBI	Business Update	PRICE SENSITIVE	26/06/19	106.19KB	Share
UBI	CEO's AGM Address to Shareholders	PRICE SENSITIVE	25/06/19	138.01KB	Share
UBI	Term Sheet Extension	PRICE SENSITIVE	30/05/19	60.89KB	Share
UBI	Q1 2019 Results	PRICE SENSITIVE	30/04/19	283.15KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/19	298.9KB	Share
UBI	FY2018 Results Presentation	PRICE SENSITIVE	08/03/19	1MB	Share
UBI	Resignation of CEO Rick Legleiter	PRICE SENSITIVE	08/03/19	151.21KB	Share
UBI	Appendix 4E and Annual Report on Form 10-K FY2018	PRICE SENSITIVE	22/02/19	425.62KB	Share
UBI	Receipt of Lump Sum Service Fees	PRICE SENSITIVE	18/02/19	59.48KB	Share
UBI	Term Sheet Agreement	PRICE SENSITIVE	11/02/19	60.8KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/19	677.51KB	Share
UBI	Business Update	PRICE SENSITIVE	20/12/18	154.75KB	Share
UBI	Prepayment of Loan	PRICE SENSITIVE	20/11/18	147.2KB	Share
UBI	Q3 FY2018 results	PRICE SENSITIVE	30/10/18	475.1KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/18	455.1KB	Share
UBI	Notice from LifeScan to buy out quarterly service fee	PRICE SENSITIVE	26/09/18	77.65KB	Share
UBI	Trading Halt	PRICE SENSITIVE	26/09/18	284.57KB	Share
UBI	Half Yearly Report and Accounts	PRICE SENSITIVE	13/08/18	492.25KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	19/07/18	424.92KB	Share
UBI	Q1 FY2018 results	PRICE SENSITIVE	27/04/18	524.37KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	24/04/18	391.25KB	Share
UBI	Appendix 4E and Annual Report on Form 10K	PRICE SENSITIVE	23/02/18	552.26KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	22/01/18	827.54KB	Share
UBI	Aggregate Quarterly Service Fees received exceed US$45m	PRICE SENSITIVE	15/11/17	185.96KB	Share
UBI	Q3 2017 Financial Results and SEC Form 10-Q	PRICE SENSITIVE	24/10/17	907.44KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	23/10/17	840.08KB	Share
UBI	Receives $7.5M under the R&D Tax Incentive	PRICE SENSITIVE	16/10/17	86.38KB	Share
UBI	Half Yearly Report and Accounts	PRICE SENSITIVE	07/08/17	634.75KB	Share
UBI	CEO appointment, Chairman succession and Board Renewal	PRICE SENSITIVE	07/08/17	206.56KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	17/07/17	830.9KB	Share
UBI	AGM Business Update	PRICE SENSITIVE	22/06/17	1.05MB	Share
UBI	Commencement of Xprecia Stride sales activities in US	PRICE SENSITIVE	08/05/17	439.48KB	Share
UBI	Q1 2017 Financial Results and SEC Form 10-Q	PRICE SENSITIVE	27/04/17	1.04MB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/17	885.51KB	Share
UBI	Preliminary Final Report	PRICE SENSITIVE	27/02/17	970.93KB	Share
UBI	Appendix 4C - quarterly	PRICE SENSITIVE	24/01/17	178.23KB	Share
UBI	Acquires Hemostasis Reference Laboratory business	PRICE SENSITIVE	19/12/16	63.82KB	Share
UBI	Update on eligibility for R&D Tax Incentive	PRICE SENSITIVE	23/11/16	60.68KB	Share

UBI Appendix 4E and Annual Report on Form 10-K FY2021
24/02/22	PRICE SENSITIVE	3.73MB	Share
UBI December 2021 Appendix 4C and Quarterly Activity Report
28/01/22	PRICE SENSITIVE	364.92KB	Share
UBI UBI launch Sentia Malic Acid Test globally
18/01/22	PRICE SENSITIVE	170.24KB	Share
UBI UBI signs deal to commercialise SARS-CoV-2 N-Protein Test
24/12/21	PRICE SENSITIVE	425.13KB	Share
UBI UBI signs Master Collaboration Agreement with Mayo Clinic
11/11/21	PRICE SENSITIVE	146.13KB	Share
UBI Investor Presentation
11/11/21	PRICE SENSITIVE	449.93KB	Share
UBI UBI signs Master Collaboration Agreement with Mayo Clinic
11/11/21	PRICE SENSITIVE	145.44KB	Share
UBI Q3 2021 Results and Market Update
29/10/21	PRICE SENSITIVE	2.52MB	Share
UBI UBI launches Regulatory Clinical Trial for Xprecia Prime
27/10/21	PRICE SENSITIVE	178.45KB	Share
UBI UBI signs USA distribution deal and Sentia sales hit $1M
25/10/21	PRICE SENSITIVE	167.03KB	Share
UBI September 2021 Appendix 4C and Quarterly Activity Report
22/10/21	PRICE SENSITIVE	295.43KB	Share
UBI UBI receives $2.8M under the R&D Tax Incentive Rebate
11/10/21	PRICE SENSITIVE	167.15KB	Share
UBI UBI signs major French distribution deal for Sentia
04/10/21	PRICE SENSITIVE	168.82KB	Share
UBI UBI extends clinical development trials for Tn Antigen
20/09/21	PRICE SENSITIVE	150.85KB	Share
UBI Peter Mac - Tn Antigen cancer biosensor trial
14/09/21	PRICE SENSITIVE	166.51KB	Share
UBI Market Update
09/09/21	PRICE SENSITIVE	340.66KB	Share
UBI Appendix 4D and Half Year Results - 30 June 2021
06/08/21	PRICE SENSITIVE	616.43KB	Share
UBI June 2021 Quarterly Activity Report and Appendix 4C
30/07/21	PRICE SENSITIVE	370.87KB	Share
UBI CEO's AGM Address to Shareholders
30/06/21	PRICE SENSITIVE	550.72KB	Share
UBI Sentia Sales Update
07/06/21	PRICE SENSITIVE	174.74KB	Share
UBI Q1 2021 Results
30/04/21	PRICE SENSITIVE	355.73KB	Share
UBI UBI signs New Zealand distribution deal for Sentia
29/04/21	PRICE SENSITIVE	193.32KB	Share
UBI Appendix 4C - quarterly
28/04/21	PRICE SENSITIVE	330.53KB	Share
UBI UBI signs South Africa distribution deal for Sentia
26/04/21	PRICE SENSITIVE	192.08KB	Share
UBI UBI signs USA distribution deal for Sentia
15/04/21	PRICE SENSITIVE	169.04KB	Share
UBI UBI signs Chilean distribution deal for Sentia
14/04/21	PRICE SENSITIVE	166.42KB	Share
UBI UBI signs exclusive deal with Deakin and Swinburne
13/04/21	PRICE SENSITIVE	141.41KB	Share
UBI UBI signs global supply agreement for new technology
09/04/21	PRICE SENSITIVE	417.95KB	Share
UBI UBI signs exclusive agreement for cancer biosensor
09/04/21	PRICE SENSITIVE	708KB	Share
UBI Trading Halt
07/04/21	PRICE SENSITIVE	252.64KB	Share
UBI Pause in Trading
07/04/21	PRICE SENSITIVE	116.09KB	Share
UBI UBI signs Canadian distribution deal
01/04/21	PRICE SENSITIVE	167.55KB	Share
UBI Appendix 4E and Annual Report on Form 10-K FY2020
24/02/21	PRICE SENSITIVE	702.62KB	Share
UBI The Future of UBI
09/02/21	PRICE SENSITIVE	712.43KB	Share
UBI 31 December 2020 Quarterly Activity & Cashflow Report
29/01/21	PRICE SENSITIVE	321.42KB	Share
UBI UBI signs USA distribution deal
27/01/21	PRICE SENSITIVE	176.55KB	Share
UBI UBI's Canadian subsidiary signs deal with Bayer AG
30/12/20	PRICE SENSITIVE	171.89KB	Share
UBI UBI Signs Global Deal with LifeScan
22/12/20	PRICE SENSITIVE	173.46KB	Share
UBI Australian Distributor Agreement for Sentia
07/12/20	PRICE SENSITIVE	176.61KB	Share
UBI Comparison Validation Study Result for Sentia
24/11/20	PRICE SENSITIVE	206.68KB	Share
UBI UBI receives $2.8 million as R&D Tax Incentive
04/11/20	PRICE SENSITIVE	174KB	Share
UBI Q3 2020 Results
29/10/20	PRICE SENSITIVE	579.24KB	Share
UBI 30 September 2020 Quarterly Activity Report
19/10/20	PRICE SENSITIVE	376.47KB	Share
UBI Update - Coagulation Business Update
08/10/20	PRICE SENSITIVE	215.85KB	Share
UBI Coagulation Business Update
06/10/20	PRICE SENSITIVE	215.65KB	Share
UBI Appendix 4D and Half Year Results - 30 June 2020
24/07/20	PRICE SENSITIVE	696.91KB	Share
UBI CEO's AGM Address to Shareholders
24/07/20	PRICE SENSITIVE	1.92MB	Share
UBI 30 June 2020 Quarterly Activity Report
17/07/20	PRICE SENSITIVE	280.85KB	Share
UBI Form 603 - JM Financial Group Limited
10/07/20	PRICE SENSITIVE	259.12KB	Share
UBI Q1 2020 Results
24/04/20	PRICE SENSITIVE	319.88KB	Share
UBI Appendix 4C - quarterly
20/04/20	PRICE SENSITIVE	250.12KB	Share
UBI Appointment of CEO
06/03/20	PRICE SENSITIVE	162.91KB	Share
UBI FY2019 Results Presentation
26/02/20	PRICE SENSITIVE	6.48MB	Share
UBI Appendix 4E and Annual Report on Form 10-K FY2019
26/02/20	PRICE SENSITIVE	662.47KB	Share
UBI Appendix 4C - quarterly
24/01/20	PRICE SENSITIVE	265.78KB	Share
UBI Q3 2019 Results
04/11/19	PRICE SENSITIVE	340.6KB	Share
UBI Appendix 4C - quarterly
29/10/19	PRICE SENSITIVE	264.27KB	Share
UBI UBI & Siemens Execute Definitive Agreements
23/09/19	PRICE SENSITIVE	59.05KB	Share
UBI Siemens Negotiations, Business Update and On-Market Buy-Back
09/09/19	PRICE SENSITIVE	278.5KB	Share
UBI Term Sheet Extension
22/08/19	PRICE SENSITIVE	61.46KB	Share
UBI Appendix 4D and Half Year Results - 30 June 2019
25/07/19	PRICE SENSITIVE	597.69KB	Share
UBI Appendix 4C - quarterly
16/07/19	PRICE SENSITIVE	393.59KB	Share
UBI Business Update
26/06/19	PRICE SENSITIVE	106.19KB	Share
UBI CEO's AGM Address to Shareholders
25/06/19	PRICE SENSITIVE	138.01KB	Share
UBI Term Sheet Extension
30/05/19	PRICE SENSITIVE	60.89KB	Share
UBI Q1 2019 Results
30/04/19	PRICE SENSITIVE	283.15KB	Share
UBI Appendix 4C - quarterly
23/04/19	PRICE SENSITIVE	298.9KB	Share
UBI FY2018 Results Presentation
08/03/19	PRICE SENSITIVE	1MB	Share
UBI Resignation of CEO Rick Legleiter
08/03/19	PRICE SENSITIVE	151.21KB	Share
UBI Appendix 4E and Annual Report on Form 10-K FY2018
22/02/19	PRICE SENSITIVE	425.62KB	Share
UBI Receipt of Lump Sum Service Fees
18/02/19	PRICE SENSITIVE	59.48KB	Share
UBI Term Sheet Agreement
11/02/19	PRICE SENSITIVE	60.8KB	Share
UBI Appendix 4C - quarterly
29/01/19	PRICE SENSITIVE	677.51KB	Share
UBI Business Update
20/12/18	PRICE SENSITIVE	154.75KB	Share
UBI Prepayment of Loan
20/11/18	PRICE SENSITIVE	147.2KB	Share
UBI Q3 FY2018 results
30/10/18	PRICE SENSITIVE	475.1KB	Share
UBI Appendix 4C - quarterly
22/10/18	PRICE SENSITIVE	455.1KB	Share
UBI Notice from LifeScan to buy out quarterly service fee
26/09/18	PRICE SENSITIVE	77.65KB	Share
UBI Trading Halt
26/09/18	PRICE SENSITIVE	284.57KB	Share
UBI Half Yearly Report and Accounts
13/08/18	PRICE SENSITIVE	492.25KB	Share
UBI Appendix 4C - quarterly
19/07/18	PRICE SENSITIVE	424.92KB	Share
UBI Q1 FY2018 results
27/04/18	PRICE SENSITIVE	524.37KB	Share
UBI Appendix 4C - quarterly
24/04/18	PRICE SENSITIVE	391.25KB	Share
UBI Appendix 4E and Annual Report on Form 10K
23/02/18	PRICE SENSITIVE	552.26KB	Share
UBI Appendix 4C - quarterly
22/01/18	PRICE SENSITIVE	827.54KB	Share
UBI Aggregate Quarterly Service Fees received exceed US$45m
15/11/17	PRICE SENSITIVE	185.96KB	Share
UBI Q3 2017 Financial Results and SEC Form 10-Q
24/10/17	PRICE SENSITIVE	907.44KB	Share
UBI Appendix 4C - quarterly
23/10/17	PRICE SENSITIVE	840.08KB	Share
UBI Receives $7.5M under the R&D Tax Incentive
16/10/17	PRICE SENSITIVE	86.38KB	Share
UBI Half Yearly Report and Accounts
07/08/17	PRICE SENSITIVE	634.75KB	Share
UBI CEO appointment, Chairman succession and Board Renewal
07/08/17	PRICE SENSITIVE	206.56KB	Share
UBI Appendix 4C - quarterly
17/07/17	PRICE SENSITIVE	830.9KB	Share
UBI AGM Business Update
22/06/17	PRICE SENSITIVE	1.05MB	Share
UBI Commencement of Xprecia Stride sales activities in US
08/05/17	PRICE SENSITIVE	439.48KB	Share
UBI Q1 2017 Financial Results and SEC Form 10-Q
27/04/17	PRICE SENSITIVE	1.04MB	Share
UBI Appendix 4C - quarterly
27/04/17	PRICE SENSITIVE	885.51KB	Share
UBI Preliminary Final Report
27/02/17	PRICE SENSITIVE	970.93KB	Share
UBI Appendix 4C - quarterly
24/01/17	PRICE SENSITIVE	178.23KB	Share
UBI Acquires Hemostasis Reference Laboratory business
19/12/16	PRICE SENSITIVE	63.82KB	Share
UBI Update on eligibility for R&D Tax Incentive
23/11/16	PRICE SENSITIVE	60.68KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.6¢		Change 0.002(8.33%)		Mkt cap ! $7.749M

Open	High	Low	Value	Volume
2.5¢	2.6¢	2.5¢	$14.86K	582.3K

Buyers (Bids)

No.	Vol.	Price($)
1	38988	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	38707	2

View Market Depth

No.	Vol.	Price($)
1	38988	0.021
4	3664725	0.020
1	50000	0.019
2	660000	0.016
1	100000	0.015

Price($)	Vol.	No.
0.026	707	1
0.027	37000	1
0.029	110482	1
0.030	298558	4
0.050	100000	1

Last trade - 10.16am 13/08/2025 (20 minute delay)

UBI (ASX) Chart

UNIVERSAL BIOSENSORS INC. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available